ICU Medical, Inc.
ICUI
อันดับในหุ้น
#4027
ICU Medical, Inc., operating globally through its subsidiaries, is a medical... ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
ราคาหุ้น
$161.56
ซิงค์ล่าสุด: 2026-10-19
มูลค่าตลาด
$4.04B
การเปลี่ยนแปลง (1 วัน)
-0.87%
การเปลี่ยนแปลง (1 ปี)
37.69%
ประเทศ
US
ซื้อขาย ICU Medical, Inc. (ICUI)
หมวดหมู่
Healthcare
รายได้ของ ICU Medical, Inc. (ICUI)
รายได้ใน Jun 2026 TTM: $-3.88M
ตามรายงานทางการเงินล่าสุดของ ICU Medical, Inc. กำไรปัจจุบันของบริษัทคือ $-3.88M ในปี 2023 บริษัทมีกำไร $-78.30M ซึ่ง มากกว่ารายได้ในปี กำไรในปี 2022 ที่อยู่ที่ $-114.41M กำไรที่แสดงในหน้านี้คือกำไรก่อนหักดอกเบี้ยและภาษี หรือที่เรียกว่า EBIT
ประวัติรายได้ของ ICU Medical, Inc. ตั้งแต่ 2000 ถึง 2026
รายได้ ณ สิ้นปีแต่ละปี
| ปี | รายได้ | เปลี่ยน |
|---|---|---|
| 2026 (TTM) | $-3.88M | -94.12% |
| 2024 | $-66.01M | -15.69% |
| 2023 | $-78.30M | -31.56% |
| 2022 | $-114.41M | -192.88% |
| 2021 | $123.19M | 26.35% |
| 2020 | $97.49M | -15.01% |
| 2019 | $114.71M | 412.68% |
| 2018 | $22.37M | -56.37% |
| 2017 | $51.28M | -39.78% |
| 2016 | $85.16M | 22.19% |
| 2015 | $69.70M | 75.16% |
| 2014 | $39.79M | -24.51% |
| 2013 | $52.71M | -14.76% |
| 2012 | $61.84M | -6.90% |
| 2011 | $66.42M | 34.44% |
| 2010 | $49.41M | 26.21% |
| 2009 | $39.15M | 8.51% |
| 2008 | $36.08M | 8.19% |
| 2007 | $33.35M | -5.63% |
| 2006 | $35.34M | 16.56% |
| 2005 | $30.32M | 304.70% |
| 2004 | $7.49M | -78.75% |
| 2003 | $35.25M | 12.14% |
| 2002 | $31.43M | 30.39% |
| 2001 | $24.11M | 28.79% |
| 2000 | $18.72M | 0.00% |
รายได้ของบริษัทหรือคู่แข่งที่คล้ายกัน
| บริษัท | รายได้ | ความแตกต่างของรายได้ | ประเทศ |
|---|---|---|---|
| $3.81B | -98,212.92% |
US
|
|
| $4.11B | -106,025.28% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | -41,089.95% |
US
|
|
| - | - |
CH
|
